company background image
530233 logo

Auro Laboratories BSE:530233 Stock Report

Last Price

₹159.15

Market Cap

₹991.9m

7D

-9.5%

1Y

144.8%

Updated

01 Mar, 2024

Data

Company Financials

Auro Laboratories Limited

BSE:530233 Stock Report

Market Cap: ₹991.9m

530233 Stock Overview

Auro Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India.

530233 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Auro Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Auro Laboratories
Historical stock prices
Current Share Price₹159.15
52 Week High₹178.00
52 Week Low₹52.50
Beta0.50
1 Month Change14.87%
3 Month Change24.58%
1 Year Change144.85%
3 Year Change77.03%
5 Year Change185.22%
Change since IPO7,625.73%

Recent News & Updates

Recent updates

Shareholder Returns

530233IN PharmaceuticalsIN Market
7D-9.5%-0.1%-1.1%
1Y144.8%68.2%46.3%

Return vs Industry: 530233 exceeded the Indian Pharmaceuticals industry which returned 68.2% over the past year.

Return vs Market: 530233 exceeded the Indian Market which returned 46.3% over the past year.

Price Volatility

Is 530233's price volatile compared to industry and market?
530233 volatility
530233 Average Weekly Movement4.8%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market3.8%

Stable Share Price: 530233's share price has been volatile over the past 3 months.

Volatility Over Time: 530233's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1989n/aSharat Deorahhttps://www.aurolabs.com

Auro Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India. It offers APIs for various drugs, such as antihistamine, muscle relaxant, diuretic, iron deficiency, anti-diabetic, anti-fungal, anti-ulcer, iodine supplement, anti-malaria, analgesics, antacids, and anti-inflammatory, as well as for other products, that includes potassium iodide, sodium iodide, and microcrystalline cellulose. The company also provides specialty chemicals comprising guanidine nitrate; dimethyl amine HCl; 2-ethoxy benzoic acid; and 3,4,5 - trimethoxy benzoic acid.

Auro Laboratories Limited Fundamentals Summary

How do Auro Laboratories's earnings and revenue compare to its market cap?
530233 fundamental statistics
Market cap₹991.90m
Earnings (TTM)₹71.92m
Revenue (TTM)₹550.97m

13.8x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
530233 income statement (TTM)
Revenue₹550.97m
Cost of Revenue₹300.78m
Gross Profit₹250.19m
Other Expenses₹178.27m
Earnings₹71.92m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)11.54
Gross Margin45.41%
Net Profit Margin13.05%
Debt/Equity Ratio41.5%

How did 530233 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.